Furthermore, subsequent studies by Liu et al. identified TMEM196 hypermethylation as a highly sensitive and noninvasive biomarker detectable in plasma and sputum, showing strong concordance with primary lung tumors and a significant association with patient age and cancer type [102]. This evidence concerns the gene TMEM196 and cancer.